Related Experiment Video

Updated: Jul 18, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Antifungal prophylaxis following reduced-intensity stem cell transplantation

M Kami1, N Murashige, Y Tanaka

  • 1Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan. kami-tky@umin.ac.jp

Transplant Infectious Disease : an Official Journal of the Transplantation Society
|November 23, 2006
PubMed

Insights

Reduced-intensity stem cell transplantation (RIST) offers a curative option for hematologic diseases. Fungal infection prophylaxis is shifting towards oral antifungals as RIST patients are increasingly managed as outpatients.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Reduced-intensity stem cell transplantation (RIST) is a novel curative option for advanced hematologic diseases.
  • RIST's minimal toxicity enables transplantation in elderly patients or those with organ dysfunction.
  • Young, healthy patients can undergo RIST as outpatients.

Purpose of the Study:

  • To highlight the evolving prophylactic strategies for fungal infections in RIST patients.
  • To emphasize the shift in fungal management focus from hospital equipment to oral antifungals.
  • To discuss the implications of RIST's outpatient management on fungal infection prophylaxis.

Main Methods:

  • Review of current literature on RIST and fungal infection management.
  • Analysis of the timing and setting of fungal infection development in RIST patients.
  • Evaluation of the role of oral antifungals in outpatient RIST settings.

Main Results:

  • Fungal infection is a significant complication in RIST with a poor prognosis.
  • The median day for fungal infection development is day 100 post-RIST, often when patients are outpatients.
  • Current prophylactic strategies need adaptation for the outpatient setting.

Conclusions:

  • Fungal infection prophylaxis in RIST requires a strategic shift towards oral antifungals.
  • The management of fungal infections post-RIST must adapt to the increasing trend of outpatient follow-up.
  • Recent advancements in antifungal therapies are expected to significantly impact future management strategies.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...